Funding

Gilgamesh Pharma

United States · Biotech · Healthtech

Develops novel chemical entities for psychiatric and neurological disorders

Visit gilgameshpharmaceutical.comFunding history

Funding history

1 round · 1 with disclosed amounts
AnnouncedRoundAmountInvestors
Series A$60MPrime Movers Lab — Role not disclosedSatori Neuro — Role not disclosed

Investors

Prime Movers LabSeries ASatori NeuroSeries A

Coverage

Mar 24, 2026Gilgamesh Pharma · Series A

Similar companies

Guoke Brain-ComputerBeijing startup developing non-invasive wearable brain-computer interfaces that combine brain-signal detection, decoding and neural modulation.Undisclosed · Seed
Pathos AIClinical-stage drug developer using AI to select therapeutic assets and guide oncology trials.$237M · Series E
Star TherapeuticsBiotechnology company discovering and developing antibody therapies for diseases with significant unmet need.$200M · Private financing
Sourcesgilgameshpharmaceutical.com ↗